ERAL1
Basic information
Region (hg38): 17:28855010-28861061
Links
Phenotypes
GenCC
Source:
- Perrault syndrome 6 (Moderate), mode of inheritance: AR
- Perrault syndrome (Supportive), mode of inheritance: AR
- Perrault syndrome 6 (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Perrault syndrome 6 | AR | Audiologic/Otolaryngologic; Obstetric | Hearing loss has been described in early childhood, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; Genetic knowledge may allow fertility preservation such as by storing eggs in woman with premature ovarian failure | Audiologic/Otolaryngologic; Obstetric | 28449065 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ERAL1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 25 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 7 | |||||
Total | 0 | 0 | 25 | 2 | 8 |
Variants in ERAL1
This is a list of pathogenic ClinVar variants found in the ERAL1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-28855042-C-T | not specified | Uncertain significance (Dec 09, 2023) | ||
17-28855052-G-C | not specified | Uncertain significance (Apr 23, 2024) | ||
17-28855056-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
17-28855060-C-T | not specified | Uncertain significance (Sep 22, 2023) | ||
17-28855107-G-A | not specified | Uncertain significance (Nov 07, 2024) | ||
17-28855115-G-A | ERAL1-related disorder | Likely benign (Apr 30, 2019) | ||
17-28855167-T-A | not specified | Uncertain significance (Jan 23, 2023) | ||
17-28855185-G-A | Perrault syndrome 6 | Uncertain significance (May 01, 2018) | ||
17-28855197-C-A | not specified | Uncertain significance (Aug 30, 2022) | ||
17-28855206-G-A | not specified | Uncertain significance (Jun 10, 2024) | ||
17-28855222-G-T | not specified | Uncertain significance (Aug 08, 2023) | ||
17-28855279-C-T | not specified | Uncertain significance (Sep 06, 2022) | ||
17-28856086-G-A | Benign (May 11, 2021) | |||
17-28856137-C-G | Benign (May 11, 2021) | |||
17-28856336-T-A | Uncertain significance (May 01, 2023) | |||
17-28856444-G-A | Benign (May 12, 2021) | |||
17-28856497-C-T | ERAL1-related disorder | Benign (Jun 27, 2019) | ||
17-28856532-A-G | not specified | Uncertain significance (Mar 16, 2024) | ||
17-28856547-G-A | ERAL1-related disorder | Likely benign (Apr 01, 2022) | ||
17-28856714-CT-C | Benign (May 20, 2021) | |||
17-28857960-A-G | not specified | Uncertain significance (Sep 08, 2024) | ||
17-28857981-A-C | not specified | Uncertain significance (Dec 14, 2024) | ||
17-28858151-A-G | ERAL1-related disorder | Likely benign (Mar 05, 2024) | ||
17-28858205-T-C | not specified | Uncertain significance (Apr 19, 2024) | ||
17-28858376-G-T | not specified | Uncertain significance (Nov 17, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ERAL1 | protein_coding | protein_coding | ENST00000254928 | 10 | 6130 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.11e-9 | 0.751 | 125688 | 0 | 60 | 125748 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.358 | 222 | 238 | 0.935 | 0.0000117 | 2831 |
Missense in Polyphen | 34 | 43.646 | 0.779 | 514 | ||
Synonymous | 1.06 | 83 | 96.2 | 0.863 | 0.00000467 | 902 |
Loss of Function | 1.47 | 17 | 24.9 | 0.683 | 0.00000134 | 253 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000264 | 0.000264 |
Ashkenazi Jewish | 0.00198 | 0.00199 |
East Asian | 0.000598 | 0.000598 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000150 | 0.000149 |
Middle Eastern | 0.000598 | 0.000598 |
South Asian | 0.0000709 | 0.0000653 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Probable GTPase that plays a role in the mitochondrial ribosomal small subunit assembly. Specifically binds the 12S mitochondrial rRNA (12S mt-rRNA) to a 33 nucleotide section delineating the 3' terminal stem-loop region. May act as a chaperone that protects the 12S mt-rRNA on the 28S mitoribosomal subunit during ribosomal small subunit assembly. {ECO:0000269|PubMed:20430825, ECO:0000269|PubMed:20604745, ECO:0000269|PubMed:28449065}.;
- Disease
- DISEASE: Perrault syndrome 6 (PRLTS6) [MIM:617565]: A form of Perrault syndrome, a sex-influenced disorder characterized by sensorineural deafness in both males and females, and ovarian dysgenesis in females. Affected females have primary amenorrhea, streak gonads, and infertility, whereas affected males show normal pubertal development and are fertile. PRLTS6 inheritance is autosomal recessive. {ECO:0000269|PubMed:28449065}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Integrated Breast Cancer Pathway;Mitochondrial translation initiation;Translation;Metabolism of proteins;Mitochondrial translation elongation;Mitochondrial translation termination;Mitochondrial translation
(Consensus)
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- loftool
- 0.298
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.150
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.543
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.965
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Eral1
- Phenotype
Gene ontology
- Biological process
- ribosomal small subunit assembly;mitochondrial translational elongation;mitochondrial translational termination
- Cellular component
- mitochondrion;mitochondrial inner membrane;mitochondrial matrix;cytosol
- Molecular function
- RNA binding;protein binding;GTP binding;rRNA binding;ribosomal small subunit binding